Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bruce F. Wesson currently holds 12,500 shares of ACURA PHARMACEUTICALS, INC (ACUR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce F. Wesson has been a net seller of ACUR stock. They have purchased $651.0K and sold $34.1M worth of shares.
Bruce F. Wesson's most recent insider trade was on Jan 2, 2024, when they sold 37,500 shares at $0.00 per share.
Bruce F. Wesson serves as Executive at ACURA PHARMACEUTICALS, INC (ACUR). They have executed 217 insider transactions totaling $34.7M over their tenure at the company.
Bruce F. Wesson holds the position of Executive at ACURA PHARMACEUTICALS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Bruce F. Wesson has shown a selling trading pattern, with $651.0K in total purchases and $34.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bruce F. Wesson was on Nov 20, 2013, when they sold $1.1M worth of MDAS shares. This transaction involved 53,893 shares at $20.54 per share.
Bruce F. Wesson currently owns 12,500 shares of ACURA PHARMACEUTICALS, INC (ACUR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bruce F. Wesson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bruce F. Wesson has 217 Form 4 filings on record as an insider at ACURA PHARMACEUTICALS, INC.
Set alerts for Bruce F. Wesson and 40,000+ other insiders.